Head-To-Head Comparison: Anteris Technologies Global (AVR) versus Its Competitors

Anteris Technologies Global (NASDAQ:AVR) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its rivals? We will compare Anteris Technologies Global to similar businesses based on the strength of its institutional ownership, dividends, earnings, risk, valuation, analyst recommendations and profitability.

Earnings and Valuation

This table compares Anteris Technologies Global and its rivals gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Anteris Technologies Global	$1.91 million	-$94.14 million	-2.92
Anteris Technologies Global Competitors	$1.88 billion	$139.14 million	9.47

Anteris Technologies Global’s rivals have higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Anteris Technologies Global and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-4,619.27%	-77.69%	-67.99%
Anteris Technologies Global Competitors	-278.24%	-150.08%	-21.87%

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Anteris Technologies Global and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1	1	3	0	2.40
Anteris Technologies Global Competitors	4273	10549	18323	829	2.46

Anteris Technologies Global currently has a consensus price target of $14.00, suggesting a potential upside of 146.05%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.26%. Given Anteris Technologies Global’s higher probable upside, analysts clearly believe Anteris Technologies Global is more favorable than its rivals.

Risk & Volatility

Anteris Technologies Global has a beta of 2.02, suggesting that its stock price is 102% more volatile than the S&P 500. Comparatively, Anteris Technologies Global’s rivals have a beta of 2.55, suggesting that their average stock price is 155% more volatile than the S&P 500.

Insider & Institutional Ownership

40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 4.5% of Anteris Technologies Global shares are owned by company insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Anteris Technologies Global rivals beat Anteris Technologies Global on 10 of the 13 factors compared.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.